Precision Medicine Supply Chain Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Clinical, Commercial), By Service (Transportation, Warehousing, Sourcing & Procurement, Others), By Product (Cell & Gene Therapies (CGT), Monoclonal Antibodies, Nucleic Acid Therapies, Vaccines, Others), By End User (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, Others), By Region and Competition, 2020-2030F
Market Overview
The Global Precision Medicine Supply Chain Logistics Market was valued at USD 7.51 Billion in 2024 and is projected to reach USD 14.25 Billion by 2030, registering a CAGR of 11.24%. This market is expanding rapidly due to the growing adoption of personalized treatments for oncology, rare diseases, and genetic conditions. Precision medicine demands the transportation of highly sensitive biologics, cell and gene therapies, and customized diagnostics—each requiring precise, temperature-controlled, time-critical, and patient-specific logistics solutions. With over 17,000 active precision medicine-related clinical trials worldwide as of 2025, the need for agile and compliant logistics infrastructure has surged. Logistics providers are increasingly focused on capabilities such as secure reverse logistics, full traceability, and site-to-patient delivery. Enhanced technologies—including IoT sensors, blockchain, and real-time analytics—are driving innovation in this space. The rise in decentralized trials is also pushing logistics models to be more flexible and patient-centric, especially for direct-to-patient delivery in complex therapy regimens.
Key Market Drivers
Rising Adoption of Cell and Gene Therapies
The increasing use of cell and gene therapies is a key growth driver in the Precision Medicine Supply Chain Logistics Market. These personalized treatments involve a complex, highly regulated sequence—from harvesting patient samples to lab processing and returning the final product—all under strict time and temperature constraints. In 2023 and 2024 alone, the FDA approved a total of 16 cell and gene therapy products, indicating strong regulatory momentum and growing manufacturing needs. These sensitive therapies require ultra-cold or cryogenic transport to maintain integrity, driving demand for advanced cold-chain logistics, real-time GPS monitoring, and compliance-driven documentation. Providers offering complete traceability, contingency protocols, and certified infrastructure are becoming essential partners for biopharma companies.
Key Market Challenges
High Complexity of Handling Personalized Therapies
Managing personalized therapies presents significant operational challenges in the precision medicine logistics ecosystem. Unlike standard pharmaceuticals, these treatments are custom-made for individual patients and must adhere to narrow time windows and stringent environmental controls. For instance, autologous therapies involve transporting a patient’s own cells to and from a specialized facility, necessitating seamless coordination, temperature integrity, and accurate labeling throughout the chain of custody. Any error—be it in customs clearance, labeling, or timing—can jeopardize treatment viability. Each shipment must align precisely with clinical and patient schedules, leaving virtually no room for deviation and amplifying the logistical complexity.
Key Market Trends
Emergence of Direct-to-Patient (DTP) Delivery Models
The growing prominence of Direct-to-Patient (DTP) delivery models is reshaping precision medicine logistics. As therapies become increasingly individualized, delivering treatment directly to patients’ homes enhances accessibility and supports decentralized clinical trials. This model improves convenience, adherence, and participation, particularly for patients in remote or mobility-limited settings. DTP logistics requires precise coordination, validated cold-chain packaging, and real-time tracking systems to maintain therapy integrity during transit. Cold chain continuity and regulatory compliance are critical, especially for sensitive biologics. Logistics providers are investing in digital infrastructure and white-glove services—such as in-person delivery, patient education, and reverse logistics—to meet these complex demands. With the continued growth of telehealth and at-home diagnostics, DTP delivery is becoming integral to modern, patient-focused precision medicine.
Key Market Players
In this report, the Global Precision Medicine Supply Chain Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Precision Medicine Supply Chain Logistics Market.
Available Customizations:
Global Precision Medicine Supply Chain Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
The Global Precision Medicine Supply Chain Logistics Market was valued at USD 7.51 Billion in 2024 and is projected to reach USD 14.25 Billion by 2030, registering a CAGR of 11.24%. This market is expanding rapidly due to the growing adoption of personalized treatments for oncology, rare diseases, and genetic conditions. Precision medicine demands the transportation of highly sensitive biologics, cell and gene therapies, and customized diagnostics—each requiring precise, temperature-controlled, time-critical, and patient-specific logistics solutions. With over 17,000 active precision medicine-related clinical trials worldwide as of 2025, the need for agile and compliant logistics infrastructure has surged. Logistics providers are increasingly focused on capabilities such as secure reverse logistics, full traceability, and site-to-patient delivery. Enhanced technologies—including IoT sensors, blockchain, and real-time analytics—are driving innovation in this space. The rise in decentralized trials is also pushing logistics models to be more flexible and patient-centric, especially for direct-to-patient delivery in complex therapy regimens.
Key Market Drivers
Rising Adoption of Cell and Gene Therapies
The increasing use of cell and gene therapies is a key growth driver in the Precision Medicine Supply Chain Logistics Market. These personalized treatments involve a complex, highly regulated sequence—from harvesting patient samples to lab processing and returning the final product—all under strict time and temperature constraints. In 2023 and 2024 alone, the FDA approved a total of 16 cell and gene therapy products, indicating strong regulatory momentum and growing manufacturing needs. These sensitive therapies require ultra-cold or cryogenic transport to maintain integrity, driving demand for advanced cold-chain logistics, real-time GPS monitoring, and compliance-driven documentation. Providers offering complete traceability, contingency protocols, and certified infrastructure are becoming essential partners for biopharma companies.
Key Market Challenges
High Complexity of Handling Personalized Therapies
Managing personalized therapies presents significant operational challenges in the precision medicine logistics ecosystem. Unlike standard pharmaceuticals, these treatments are custom-made for individual patients and must adhere to narrow time windows and stringent environmental controls. For instance, autologous therapies involve transporting a patient’s own cells to and from a specialized facility, necessitating seamless coordination, temperature integrity, and accurate labeling throughout the chain of custody. Any error—be it in customs clearance, labeling, or timing—can jeopardize treatment viability. Each shipment must align precisely with clinical and patient schedules, leaving virtually no room for deviation and amplifying the logistical complexity.
Key Market Trends
Emergence of Direct-to-Patient (DTP) Delivery Models
The growing prominence of Direct-to-Patient (DTP) delivery models is reshaping precision medicine logistics. As therapies become increasingly individualized, delivering treatment directly to patients’ homes enhances accessibility and supports decentralized clinical trials. This model improves convenience, adherence, and participation, particularly for patients in remote or mobility-limited settings. DTP logistics requires precise coordination, validated cold-chain packaging, and real-time tracking systems to maintain therapy integrity during transit. Cold chain continuity and regulatory compliance are critical, especially for sensitive biologics. Logistics providers are investing in digital infrastructure and white-glove services—such as in-person delivery, patient education, and reverse logistics—to meet these complex demands. With the continued growth of telehealth and at-home diagnostics, DTP delivery is becoming integral to modern, patient-focused precision medicine.
Key Market Players
- Almac Group Limited
- Catalent, Inc.
- Parexel International Corporation
- IQVIA Holdings Inc.
- Thermo Fisher Scientific Inc.
- DHL International GmbH
- Federal Express Corporation
- UPS Healthcare
- Gxo Logistics, Inc.
- Marken Limited
In this report, the Global Precision Medicine Supply Chain Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Precision Medicine Supply Chain Logistics Market, By Type:
- Clinical
- Commercial
- Precision Medicine Supply Chain Logistics Market, By Service:
- Transportation
- Warehousing
- Sourcing & Procurement
- Others
- Precision Medicine Supply Chain Logistics Market, By Product:
- Cell & Gene Therapies (CGT)
- Monoclonal Antibodies
- Nucleic Acid Therapies
- Vaccines
- Others
- Precision Medicine Supply Chain Logistics Market, By End User:
- Pharmaceutical and Biopharmaceutical Companies
- Clinical Research Organizations
- Others
- Precision Medicine Supply Chain Logistics Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Precision Medicine Supply Chain Logistics Market.
Available Customizations:
Global Precision Medicine Supply Chain Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. VOICE OF CUSTOMER
5. GLOBAL PRECISION MEDICINE SUPPLY CHAIN LOGISTICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Clinical, Commercial)
5.2.2. By Service (Transportation, Warehousing, Sourcing & Procurement, Others)
5.2.3. By Product (Cell & Gene Therapies (CGT), Monoclonal Antibodies, Nucleic Acid Therapies, Vaccines, Others)
5.2.4. By End User (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, Others)
5.2.5. By Company (2024)
5.2.6. By Region
5.3. Market Map
6. NORTH AMERICA PRECISION MEDICINE SUPPLY CHAIN LOGISTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Service
6.2.3. By Product
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Precision Medicine Supply Chain Logistics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Service
6.3.1.2.3. By Product
6.3.1.2.4. By End User
6.3.2. Mexico Precision Medicine Supply Chain Logistics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Service
6.3.2.2.3. By Product
6.3.2.2.4. By End User
6.3.3. Canada Precision Medicine Supply Chain Logistics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Service
6.3.3.2.3. By Product
6.3.3.2.4. By End User
7. EUROPE PRECISION MEDICINE SUPPLY CHAIN LOGISTICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Service
7.2.3. By Product
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Precision Medicine Supply Chain Logistics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Service
7.3.1.2.3. By Product
7.3.1.2.4. By End User
7.3.2. Germany Precision Medicine Supply Chain Logistics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Service
7.3.2.2.3. By Product
7.3.2.2.4. By End User
7.3.3. United Kingdom Precision Medicine Supply Chain Logistics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Service
7.3.3.2.3. By Product
7.3.3.2.4. By End User
7.3.4. Italy Precision Medicine Supply Chain Logistics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Service
7.3.4.2.3. By Product
7.3.4.2.4. By End User
7.3.5. Spain Precision Medicine Supply Chain Logistics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Service
7.3.5.2.3. By Product
7.3.5.2.4. By End User
8. ASIA-PACIFIC PRECISION MEDICINE SUPPLY CHAIN LOGISTICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Service
8.2.3. By Product
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Precision Medicine Supply Chain Logistics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Service
8.3.1.2.3. By Product
8.3.1.2.4. By End User
8.3.2. India Precision Medicine Supply Chain Logistics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Service
8.3.2.2.3. By Product
8.3.2.2.4. By End User
8.3.3. South Korea Precision Medicine Supply Chain Logistics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Service
8.3.3.2.3. By Product
8.3.3.2.4. By End User
8.3.4. Japan Precision Medicine Supply Chain Logistics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Service
8.3.4.2.3. By Product
8.3.4.2.4. By End User
8.3.5. Australia Precision Medicine Supply Chain Logistics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Service
8.3.5.2.3. By Product
8.3.5.2.4. By End User
9. SOUTH AMERICA PRECISION MEDICINE SUPPLY CHAIN LOGISTICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Service
9.2.3. By Product
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Precision Medicine Supply Chain Logistics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Service
9.3.1.2.3. By Product
9.3.1.2.4. By End User
9.3.2. Argentina Precision Medicine Supply Chain Logistics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Service
9.3.2.2.3. By Product
9.3.2.2.4. By End User
9.3.3. Colombia Precision Medicine Supply Chain Logistics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Service
9.3.3.2.3. By Product
9.3.3.2.4. By End User
10. MIDDLE EAST AND AFRICA PRECISION MEDICINE SUPPLY CHAIN LOGISTICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Service
10.2.3. By Product
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Precision Medicine Supply Chain Logistics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Service
10.3.1.2.3. By Product
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Precision Medicine Supply Chain Logistics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Service
10.3.2.2.3. By Product
10.3.2.2.4. By End User
10.3.3. UAE Precision Medicine Supply Chain Logistics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Service
10.3.3.2.3. By Product
10.3.3.2.4. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. DISRUPTIONS: CONFLICTS, PANDEMICS AND TRADE BARRIERS
14. PORTERS FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Almac Group Limited
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Catalent, Inc.
15.3. Parexel International Corporation
15.4. IQVIA Holdings Inc.
15.5. Thermo Fisher Scientific Inc.
15.6. DHL International GmbH
15.7. Federal Express Corporation
15.8. UPS Healthcare
15.9. GXO Logistics, Inc.
15.10. Marken Limited
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. VOICE OF CUSTOMER
5. GLOBAL PRECISION MEDICINE SUPPLY CHAIN LOGISTICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Clinical, Commercial)
5.2.2. By Service (Transportation, Warehousing, Sourcing & Procurement, Others)
5.2.3. By Product (Cell & Gene Therapies (CGT), Monoclonal Antibodies, Nucleic Acid Therapies, Vaccines, Others)
5.2.4. By End User (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, Others)
5.2.5. By Company (2024)
5.2.6. By Region
5.3. Market Map
6. NORTH AMERICA PRECISION MEDICINE SUPPLY CHAIN LOGISTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Service
6.2.3. By Product
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Precision Medicine Supply Chain Logistics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Service
6.3.1.2.3. By Product
6.3.1.2.4. By End User
6.3.2. Mexico Precision Medicine Supply Chain Logistics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Service
6.3.2.2.3. By Product
6.3.2.2.4. By End User
6.3.3. Canada Precision Medicine Supply Chain Logistics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Service
6.3.3.2.3. By Product
6.3.3.2.4. By End User
7. EUROPE PRECISION MEDICINE SUPPLY CHAIN LOGISTICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Service
7.2.3. By Product
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Precision Medicine Supply Chain Logistics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Service
7.3.1.2.3. By Product
7.3.1.2.4. By End User
7.3.2. Germany Precision Medicine Supply Chain Logistics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Service
7.3.2.2.3. By Product
7.3.2.2.4. By End User
7.3.3. United Kingdom Precision Medicine Supply Chain Logistics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Service
7.3.3.2.3. By Product
7.3.3.2.4. By End User
7.3.4. Italy Precision Medicine Supply Chain Logistics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Service
7.3.4.2.3. By Product
7.3.4.2.4. By End User
7.3.5. Spain Precision Medicine Supply Chain Logistics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Service
7.3.5.2.3. By Product
7.3.5.2.4. By End User
8. ASIA-PACIFIC PRECISION MEDICINE SUPPLY CHAIN LOGISTICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Service
8.2.3. By Product
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Precision Medicine Supply Chain Logistics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Service
8.3.1.2.3. By Product
8.3.1.2.4. By End User
8.3.2. India Precision Medicine Supply Chain Logistics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Service
8.3.2.2.3. By Product
8.3.2.2.4. By End User
8.3.3. South Korea Precision Medicine Supply Chain Logistics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Service
8.3.3.2.3. By Product
8.3.3.2.4. By End User
8.3.4. Japan Precision Medicine Supply Chain Logistics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Service
8.3.4.2.3. By Product
8.3.4.2.4. By End User
8.3.5. Australia Precision Medicine Supply Chain Logistics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Service
8.3.5.2.3. By Product
8.3.5.2.4. By End User
9. SOUTH AMERICA PRECISION MEDICINE SUPPLY CHAIN LOGISTICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Service
9.2.3. By Product
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Precision Medicine Supply Chain Logistics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Service
9.3.1.2.3. By Product
9.3.1.2.4. By End User
9.3.2. Argentina Precision Medicine Supply Chain Logistics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Service
9.3.2.2.3. By Product
9.3.2.2.4. By End User
9.3.3. Colombia Precision Medicine Supply Chain Logistics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Service
9.3.3.2.3. By Product
9.3.3.2.4. By End User
10. MIDDLE EAST AND AFRICA PRECISION MEDICINE SUPPLY CHAIN LOGISTICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Service
10.2.3. By Product
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Precision Medicine Supply Chain Logistics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Service
10.3.1.2.3. By Product
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Precision Medicine Supply Chain Logistics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Service
10.3.2.2.3. By Product
10.3.2.2.4. By End User
10.3.3. UAE Precision Medicine Supply Chain Logistics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Service
10.3.3.2.3. By Product
10.3.3.2.4. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. DISRUPTIONS: CONFLICTS, PANDEMICS AND TRADE BARRIERS
14. PORTERS FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Almac Group Limited
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Catalent, Inc.
15.3. Parexel International Corporation
15.4. IQVIA Holdings Inc.
15.5. Thermo Fisher Scientific Inc.
15.6. DHL International GmbH
15.7. Federal Express Corporation
15.8. UPS Healthcare
15.9. GXO Logistics, Inc.
15.10. Marken Limited
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
